BaroPharm Selected for MSME's '2025 R&D Top 50 Excellent Achievements' for Pharmaceutical Distribution Innovation

## BaroPharm's Technology Leading Pharmacy Innovation Recognized! A Triumph in the Ministry of SMEs and Startups' R&D Top 50 Outstanding Achievements BaroPharm, a total platform company injecting new life into pharmacy management, proudly made its name on the '2025 Small and Medium-sized Enterprise Technology Development (R&D) Top 50 Outstanding Achievements,' hosted by the Ministry of SMEs and Startups, showcasing its innovative technology both domestically and internationally. This achievement, made amidst fierce competition, further raises expectations for the positive changes BaroPharm will bring to the pharmacy ecosystem. The 'Top 50 Outstanding Achievements' is an honorable program that strictly selects only 50 companies from among those that have successfully completed Ministry of SMEs and Startups R&D support projects in the last five years and have generated outstanding results. This year, a total of 360 companies applied, marking the highest-ever competition rate of 7.2 to 1, and BaroPharm passed this rigorous evaluation, earning recognition for its excellence in key areas such as commercialization and strategic technology. The core technology for which BaroPharm received recognition this time is the 'Big Data-Based Pharmaceutical Distribution Optimization and Delivery Sharing Platform.' This innovative platform precisely analyzes the vast amount of real-time pharmaceutical supply and demand data generated in pharmacies and presents an optimal ordering system. Through this, it maximizes logistics cost reduction and overall system efficiency, and has dramatically reduced the chronic burden of inventory that pharmacies have long faced. It is evaluated as having significantly contributed to the stable operation of pharmacies by mitigating the risks of stockouts and excess inventory. With this selection, BaroPharm has secured not just honor, but also tangible growth momentum. In addition to a commendation from the Minister of SMEs and Startups, it will receive various incentives, including support for exhibition participation to enter the global market, and customized financial and investment linkages. BaroPharm stated, "The key factor in this selection was that technology development directly led to actual sales growth and business expansion," emphasizing the market applicability and impact of its technology. A BaroPharm official stated, "We are very pleased that our sincere efforts to solve the difficulties faced by the pharmacy ecosystem with technology and data have been recognized at the national level." They continued, "We will continuously advance big data and platform technologies to build a future-oriented ecosystem where all pharmacy-related services are organically connected and operate efficiently," revealing a firm vision and ambition. BaroPharm's achievement this time goes beyond pharmacy management innovation, and will serve as an opportunity to once again prove its potential to lead the future of the domestic healthcare distribution sector.